Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Friday, December 06, 2019
ChromaDex has announced the expansion of its partnership with Matakana Health (MHL) until early 2023, which will now include Australia in its territory.
read more
Cipla has received final approval for its ANDA for Icatibant Injectable 30mg/3mL from the FDA.
read more
Wednesday, January 22, 2020
Civica Rx has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.
read more
Wednesday, December 18, 2019
Civica Rx and Hikma Pharmaceuticals announced imminent shipments of Heparin Sodium Injection, USP, and seven other essential injectable medicines.
read more
Civica Rx has announced plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, Virginia.
read more
Saturday, September 25, 2021
Clean Cells, part of the Clean Biologics group, a provider of biopharmaceutical product quality control services and manufacturer of starting materials, announced an investment of €13M ($15.3M) for a new production facility in Montaigu-Vendée. By ...
read more
Clearside Biomedical announced an update to the XIPERE NDA resubmission timeline and to its commercialization and development partnership with Bausch Health and Bausch + Lomb, its global eye health business.
read more
Clinipace Worldwide has launched a new regulatory and strategic development consultancy called RSD Global Consulting.
read more
Friday, December 16, 2022
CluePoints, announced Andy Cooper has been appointed as its new Chief Executive Officer. Cooper succeeds Co-Founder, Francois Torche, who is stepping back as CEO to focus his full attention on the strategic direction of CluePoints’ world-leading ...
read more
Monday, September 09, 2019
CMAB Biopharma announced a positive opinion in an external European quality audit conducted by Parexel International.
read more
Monday, December 09, 2019
CMAB Biopharma and Shenzhen Fapon Biopharma announced a comprehensive strategic agreement for the development and manufacturing of an undisclosed biologic drug project.
read more
Wednesday, September 04, 2019
CMAB Biopharma and Kintor announced a comprehensive strategic cooperation agreement for the development and manufacturing of ALK-1 monoclonal antibody (mAb).
read more
CMC Biologics, Inc., a global leader in process development and contract
manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company
focused on discovering and developing innovative monoclonal antibody-based ...
read more
CMC Biologics, Inc., a global leader in process development and contract manufacturing, and MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based ...
read more
Tuesday, December 29, 2015
CMC Biologics, Inc. today announced that they have entered into an agreement with Immunocore Limited, a leading UK-based biotechnology company focused on developing new treatments for cancer, viral infections and autoimmune diseases, for the process ...
read more